Patrick Steadman retweetledi

Only possible with #teamscience @NatureMedicine
Grateful to #coauthors #collaborators #funders
#meningioma #patients
@UHN @KBI_UHN @UHN_Surgery
@BrainTumourOrg @TheVFoundation @CIHR_IRSC @theNCI @NRGonc @UofT
@ICOMeningioma
bit.ly/3AuTaxr
Justin Z. Wang@justinzw
This is important as Proliferative meningiomas can be found across all WHO grades, including in the RTOG-0539 clinical trial cases, which we were able to reclassify into Molecular Groups to reproduce the same findings, suggesting Molecular Classification can resolve some of the significant heterogeneity in outcomes seen with these tumors, particularly after RT
English








































